Fungal Meningitis Outbreak Investigation
The Ohio Department of Health and Ohio local health jurisdictions are collaborating with the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA) and other state and local health departments in the investigation of a multistate outbreak of fungal meningitis and other infections among patients who received contaminated preservative-free methylprednisolone acetate steroid injections from the New England Compounding Center.
Up-to-date information about this multistate outbreak investigation, including state-level case counts, can be found at the CDC website.
FDA updates, including information on FDA actions and recommendations, can be found on the FDA website.
Questions can be directed to ODH, Outbreak Response and Bioterrorism Investigation Team at 614-995-5599 or ORBIT@odh.ohio.gov.